News: Notice of the forthcoming Retina UK AGM – September 2024
Formal notice of the forthcoming Annual General Meeting in September 2024.
Search results
Formal notice of the forthcoming Annual General Meeting in September 2024.
ProQR has published the top-line results from its Phase 2/3 “Illuminate” trial of the RNA therapy sepofarsen for Leber congenital amaurosis type 10 caused by a specific mutation in the CEP290 gene.
A round-up of the latest research into inherited retinal conditions - February 2024.
With all the interest in exciting gene and cell therapies for inherited sight loss, it’s easy to forget that more traditional drugs can also hold promise.
The BBC World Service has undertaken an investigation of unproven treatments for retinitis pigmentosa (RP) and has produced a documentary film, called Blind Faith, which is available on BBC iPlayer.
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
Whether you are looking for practical information or emotional support, online, by phone or face-to-face, we’re here to help.
This edition includes exciting news about our Annual and Professionals’ Conferences. We hope as many of you as possible can join us in Manchester, or online, in September. You’ll also find updates about the latest research and a feature on one of our funded researchers, Dr Jörn Lakowski.
Inside this edition, set yourself a challenge in 2024, plus find out about our brand new lottery.
Inside this edition, register now for our AI webinar on 7 December with Dr Nikolas Pontikos.